Cargando…
Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization
This research primarily focuses on the development of innovative topical nanoemulsions for etodolac, aimed at surmounting its inherent limitations. The preparation of etodolac nanoemulsions is accomplished through a combination of high shear homogenization and ultrasonication methods. The optimizati...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610052/ https://www.ncbi.nlm.nih.gov/pubmed/37896270 http://dx.doi.org/10.3390/pharmaceutics15102510 |
_version_ | 1785128159939657728 |
---|---|
author | Özdemir, Samet Üner, Burcu Karaküçük, Alptuğ Çelik, Burak Sümer, Engin Taş, Çetin |
author_facet | Özdemir, Samet Üner, Burcu Karaküçük, Alptuğ Çelik, Burak Sümer, Engin Taş, Çetin |
author_sort | Özdemir, Samet |
collection | PubMed |
description | This research primarily focuses on the development of innovative topical nanoemulsions for etodolac, aimed at surmounting its inherent limitations. The preparation of etodolac nanoemulsions is accomplished through a combination of high shear homogenization and ultrasonication methods. The optimization of the formulation components is systematically conducted using the design of experiments methodology. The droplet size (DS), polydispersity index (PDI), and zeta potential (ZP) of the optimized formulation were assessed using the differential light scattering (DLS) technique. Surface morphology examinations were conducted using electron microscopy, while interactions between excipients and the drug were analyzed through FTIR analysis. Additionally, in vitro release and ex vivo permeability studies were carried out. Furthermore, anti-inflammatory activity was evaluated in the context of a carrageenan-induced paw edema model in rats. The DS, PDI, and ZP of the optimal formulation were 163.5 nm, 0.141, and −33.1 mV, respectively. The in vitro release profile was assessed as a sustained release by following a non-Fickian drug transport. The flux of etodolac nanoemulsions and coarse dispersions were 165.7 ± 11.7 µg/cm(2) h and 59.7 ± 15.2 µg/cm(2) h, respectively. Enhanced edema inhibition was observed at 13.4%, 36.5%, and 50.65% for the 6th, 8th, and 24th hours, respectively. Taken together, these results confirmed that nanoemulsions are promising carriers for the topical delivery of etodolac. |
format | Online Article Text |
id | pubmed-10610052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106100522023-10-28 Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization Özdemir, Samet Üner, Burcu Karaküçük, Alptuğ Çelik, Burak Sümer, Engin Taş, Çetin Pharmaceutics Article This research primarily focuses on the development of innovative topical nanoemulsions for etodolac, aimed at surmounting its inherent limitations. The preparation of etodolac nanoemulsions is accomplished through a combination of high shear homogenization and ultrasonication methods. The optimization of the formulation components is systematically conducted using the design of experiments methodology. The droplet size (DS), polydispersity index (PDI), and zeta potential (ZP) of the optimized formulation were assessed using the differential light scattering (DLS) technique. Surface morphology examinations were conducted using electron microscopy, while interactions between excipients and the drug were analyzed through FTIR analysis. Additionally, in vitro release and ex vivo permeability studies were carried out. Furthermore, anti-inflammatory activity was evaluated in the context of a carrageenan-induced paw edema model in rats. The DS, PDI, and ZP of the optimal formulation were 163.5 nm, 0.141, and −33.1 mV, respectively. The in vitro release profile was assessed as a sustained release by following a non-Fickian drug transport. The flux of etodolac nanoemulsions and coarse dispersions were 165.7 ± 11.7 µg/cm(2) h and 59.7 ± 15.2 µg/cm(2) h, respectively. Enhanced edema inhibition was observed at 13.4%, 36.5%, and 50.65% for the 6th, 8th, and 24th hours, respectively. Taken together, these results confirmed that nanoemulsions are promising carriers for the topical delivery of etodolac. MDPI 2023-10-23 /pmc/articles/PMC10610052/ /pubmed/37896270 http://dx.doi.org/10.3390/pharmaceutics15102510 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Özdemir, Samet Üner, Burcu Karaküçük, Alptuğ Çelik, Burak Sümer, Engin Taş, Çetin Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization |
title | Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization |
title_full | Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization |
title_fullStr | Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization |
title_full_unstemmed | Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization |
title_short | Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization |
title_sort | nanoemulsions as a promising carrier for topical delivery of etodolac: formulation development and characterization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610052/ https://www.ncbi.nlm.nih.gov/pubmed/37896270 http://dx.doi.org/10.3390/pharmaceutics15102510 |
work_keys_str_mv | AT ozdemirsamet nanoemulsionsasapromisingcarrierfortopicaldeliveryofetodolacformulationdevelopmentandcharacterization AT unerburcu nanoemulsionsasapromisingcarrierfortopicaldeliveryofetodolacformulationdevelopmentandcharacterization AT karakucukalptug nanoemulsionsasapromisingcarrierfortopicaldeliveryofetodolacformulationdevelopmentandcharacterization AT celikburak nanoemulsionsasapromisingcarrierfortopicaldeliveryofetodolacformulationdevelopmentandcharacterization AT sumerengin nanoemulsionsasapromisingcarrierfortopicaldeliveryofetodolacformulationdevelopmentandcharacterization AT tascetin nanoemulsionsasapromisingcarrierfortopicaldeliveryofetodolacformulationdevelopmentandcharacterization |